Finland· FI-REL-REL2179

Insulin Lente Mc

A insuline und analoga zur injektion, intermediär wirkend, kombinationen product containing insulinum monocomponent. amorphicum (porcine) (lat.) + insulinum monocomponent. crystallisatum (bovine) (lat.), registered in Finland by Novo Nordisk A/S.

ATC A10AC30

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedInsulin Lente McATCA10AC30REGISTER NO.FI-REL-REL2179PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Active substance
Insulinum monocomponent. amorphicum (porcine) (lat.) + Insulinum monocomponent. crystallisatum (bovine) (lat.)
Manufacturer
Novo Nordisk A/S
Country
Finland (FI)
ATC code
A10AC30
ATC class
Insuline und Analoga zur Injektion, intermediär wirkend, Kombinationen
Defined daily dose
40 E, P
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for insuline und analoga zur injektion, intermediär wirkend, kombinationen.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Insuline und analoga zur injektion, intermediär wirkend, kombinationen · interactions on record

1 record

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ba6260c5-fa41-4770-befc-e9bbd3212c42
GET /v1/drugs/ba6260c5-fa41-4770-befc-e9bbd3212c42?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "40",
  "form": "injektioneste",
  "route": null,
  "ddd_unit": "U",
  "strength": "100 IU/ml",
  "atc_label": "yhdistelmävalmisteet",
  "ma_number": "9549",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL2179",
  "authorised_at": "1987-10-21"
}

See everything about insuline und analoga zur injektion, intermediär wirkend, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.